Posts in category Long Ideas


ACADIA Pharmaceuticals Inc. (ACAD) Gets a Price Target Jump; Here’s Why

One of Wall Street’s best performing analysts sees strong long-term care growth for ACAD’s Nuplazid.

Read more

Square Inc (SQ) Gets a Price Target Lift on Expectations for More Rapid-Fire Growth Ahead

Joseph Foresi boosts his price target on SQ by $10 as the company captures more market share.

Read more

Facebook Inc (FB) Draws a Bull’s Price Target Boost After Crushing Q3 Earnings Expectations

Wedbush: FB’s growth continues to fire up internationally, solidifying strong standing against competitors.

Read more

Shopify Inc (US) (SHOP) Proves Its Growth Can Outpace Its Rivals, Asserts Analyst Darren Aftahi

Roth Capital is impressed that SHOP’s model shows off scaled profitability in robust 3Q turnout.

Read more

H.C. Wainwright Gets More Confident On Aurinia Pharmaceuticals Inc (AUPH); Here’s Why

Ed Arce lifts his price target on AUPH after recent R&D day widened doors to voclosporin’s opportunity.

Read more

Intel Corporation (INTC) Gets a Price Target Bump from Roth Capital Following Data-Centric Strong 3Q Showcase

Suji Desilva believes INTC is experiencing its best growth yet in data center segments.

Read more

Ardelyx Inc (ARDX) Hits the Home Run; BTIG Boosts Price Target

Tim Chiang now sees a bigger per share value for ARDX’s tenapanor in the IBS-C market.

Read more

H.C. Wainwright Says Don’t Write Off MannKind Corporation (MNKD) Just Yet; Bullish Bet Sends Shares Racing 25%

Oren Livnat expects MannKind’s inhaled insulin’s new label will be a real game-changer.

Read more

These Analysts Are Getting More Confident on NVIDIA Corporation (NVDA) and Intel Corporation (INTC) – Here’s Why

One analyst likes Nvidia’s stellar fall video game slate; top analyst cheers Intel’s improved Notebook sales.

Read more

Alnylam Pharmaceuticals, Inc. (ALNY) Picks Up a Price Target Boost from Cowen Following Stellar Phase III Top-Line Data in FAP

Analyst praises Alnylam’s patisiran as best-in-class, even more confident in its safety and tolerability profile.

Read more